Sensitivity tests on human cancers to select active drugs for clinical cancer therapy.
D000362:Agar; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001152:Arsenicals / Q000494:pharmacology; D001943:Breast Neoplasms / Q000201:enzymology; D002470:Cell Survival / Q000187:drug effects; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003864:Depression, Chemical; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D006801:Humans; D066298:In Vitro Techniques; D007461:Iodoacetates / Q000494:pharmacology; D007962:Leukocytes / Q000201:enzymology; D051379:Mice; D009369:Neoplasms / Q000201:enzymology / Q000378:metabolism; D013385:Succinate Dehydrogenase / Q000037:antagonists & inhibitors; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000970:Antineoplastic Agents; D001152:Arsenicals; D004273:DNA, Neoplasm; D007461:Iodoacetates; D014316:Tritium; D000362:Agar; D013385:Succinate Dehydrogenase; D004254:DNA Nucleotidyltransferases; D013936:Thymidine